Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to Cetuximab.
about
Multicenter Phase II Study of Panitumumab in Platinum Pretreated, Advanced Head and Neck Squamous Cell Cancer.Gene Expression Signatures for Head and Neck Cancer Patient Stratification: Are Results Ready for Clinical Application?Basal subtype is predictive for response to cetuximab treatment in patient-derived xenografts of squamous cell head and neck cancer.Integrative miRNA-Gene Expression Analysis Enables Refinement of Associated Biology and Prediction of Response to Cetuximab in Head and Neck Squamous Cell Cancer.Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies?Identification of Novel Signal Transduction, Immune Function, and Oxidative Stress Genes and Pathways by Topiramate for Treatment of Methamphetamine Dependence Based on Secondary Outcomes.Intragenic DNA methylation of PITX1 and the adjacent long non-coding RNA C5orf66-AS1 are prognostic biomarkers in patients with head and neck squamous cell carcinomas.Integrated time course omics analysis distinguishes immediate therapeutic response from acquired resistance.BET inhibition overcomes receptor tyrosine kinase-mediated cetuximab resistance in HNSCC.Prediction of Target Genes and Pathways Associated With Cetuximab Insensitivity in Colorectal CancerAn impaired hepatic clock system effects lipid metabolism in rats with nephropathy
P2860
Q33898889-AE4B15AA-2D7F-48F2-BAFF-BCDB3DA0AEE0Q38687552-EE5D835E-311F-4E2C-9809-B0B21BF8ED76Q38754811-86BA4A92-BF24-412B-A2FC-63E9D0A55C36Q39015086-63483318-5A71-4D28-BDAB-47F8C2840000Q47165377-9B8C7871-23CC-4745-995C-8F769F24CED1Q49532909-F8A98AD6-58EE-487B-B14C-CF17300EA47EQ50099281-072F6D72-4902-49A1-A40A-32B0E97D1956Q54964630-44359132-250E-4250-AB0C-37EF498E5C57Q54978430-B4E83FFC-65F0-462E-B89F-B3801019186BQ58583964-9A731E94-2C4B-44E0-9DF3-3682771C48F2Q58716677-836012D4-BDD6-4DF7-8230-D12A777DD549
P2860
Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to Cetuximab.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Functional Genomics Uncover th ...... Cancer Patients to Cetuximab.
@en
Functional Genomics Uncover th ...... Cancer Patients to Cetuximab.
@nl
type
label
Functional Genomics Uncover th ...... Cancer Patients to Cetuximab.
@en
Functional Genomics Uncover th ...... Cancer Patients to Cetuximab.
@nl
prefLabel
Functional Genomics Uncover th ...... Cancer Patients to Cetuximab.
@en
Functional Genomics Uncover th ...... Cancer Patients to Cetuximab.
@nl
P2093
P50
P1476
Functional Genomics Uncover th ...... l Cancer Patients to Cetuximab
@en
P2093
Andrea P Sponghini
Barbara Cortelazzi
Edoardo Marchesi
Federica Favales
Marco Giannoccaro
Marco Siano
Maria Cossu Rocca
Silvana Canevari
Silvana Pilotti
P304
P356
10.1158/1078-0432.CCR-15-2547
P407
P577
2016-02-26T00:00:00Z